wegovy semaglutide news - Search News

Novo Nordisk, Wegovy

Barron's on MSN · 22h

Novo’s Wegovy Gets Backing of a Regulator for Heart Condition Treatment. FDA Could Be Next.

Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions. Approval in the U.S.–Novo’s biggest market for obesity drugs–by the Food and Drug Administration could be next.

Benzinga.com · 1d

European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart failure symptoms, physical limitations, and exercise function in patients with obesity-related HFpEF.

Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits

The company noted that Wegovy is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise function in people with obesity-related heart failure with preserved ejection fraction (HFpEF).

The Wall Street Journal on MSN · 1d

Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.

EMA committee recommends Novo Nordisk’s Wegovy label update to reflect reduced heart failure symptoms and improved physical function

Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...

GlobalData on MSN1d

EMA CHMP recommends label update to Novo Nordisk’s Wegovy

Committee for Medicinal Products for Human Use (CHMP) has recommended an update to Novo Nordisk’s Wegovy (semaglutide 2.4 mg) ...

Compounded semaglutide is an ill-defined public health crisis

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

2d

Hims & Hers offers compounded Wegovy for $99 a month to select professions

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

11d

Wegovy, Ozempic may someday be available as monthly injection

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

Everyday Health7d

Wegovy May Reduce the Risk of Death From COVID-19, Study Suggests

A new study found that people taking Wegovy during the pandemic were 33 percent less likely to die of COVID-19.

Semaglutide Bests Liraglutide in Long-Term Weight Loss

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

8d

Experimental Weight Loss Drug Beat Ozempic and Wegovy in Early Trial

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

healthday on MSN11d

Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of ...

Is Wegovy really a gamechanger for heart health? A consultant cardiologist gives his verdict

The weight-loss jab Wegovy has been hailed as an “absolute game-changer” after a new study showed that it relieved symptoms ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results